Ignite Creation Date:
2025-12-24 @ 10:01 PM
Ignite Modification Date:
2025-12-25 @ 7:37 PM
Study NCT ID:
NCT04878432
Status:
TERMINATED
Last Update Posted:
2025-10-16
First Post:
2021-05-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS
Sponsor:
Novartis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CMBG453B1US01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None